MedTrace Logo

Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)

NCT03050242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2018-05-24

No results posted yet for this study

Summary

This study is intended to evaluate the efficacy and safety of glycopyrrolate as an antisialagogue prior to intubation with the rigid-videostylet(Optiscope®) in the general anesthesia settings. Upper airway secretions limit the use of the videostylet during during endotracheal intubation. Therefore, in this study, patients will be allocated to either of the two groups according to the administration of glycopyrrolate and the effect of glycopyrrolate in reducing oral secretions will be assessed by the observer while intubating with the rigid-videostylet. The efficacy of the antisialagogic effect on the view during endotracheal intubation will be evaluated.

Conditions

  • Cholecystitis, Acute

Interventions

DRUG

Glycopyrrolate

Intramuscular administration of glycopyrrolate 0.005mg/kg 1 hour before the surgery

Sponsors & Collaborators

  • Eunah Cho, MD

    lead OTHER

Principal Investigators

  • Eunah Cho, M.D. · Kangbuk Samsung Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-13
Primary Completion
2017-05-18
Completion
2017-05-19

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03050242 on ClinicalTrials.gov